Clinical Trials Browser

Phase 1 × EC regimen × Clear all

Breast Neoplasms, Neutropenia

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors